Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The objective of our study is to investigate whether the substitution of the standard locking
solution with a locking solution containing taurolidine and urokinase weekly (Taurolock ™ U
25,000 - www.taurolock.com ) reduces the rate of catheter dysfunction in hemodialysis
patients with a history of TCC dysfunction requiring urokinase therapy.